NORD logo

Nordicus Partners CorporationOTCPK:NORD Stock Report

Market Cap US$75.6m
Share Price
n/a
1Y29.2%
7D-1.5%
1D-1.5%
Portfolio Value
​
View

Nordicus Partners Corporation

OTCPK:NORD Stock Report

Market Cap: US$75.6m

Nordicus Partners (NORD) Stock Overview

A biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. More details

NORD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Risk Analysis

Earnings have declined by 18.8% per year over past 5 years

Makes less than USD$1m in revenue ($0)

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($76M)


NORD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW439,039 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
439,039 investors already sharing narratives
View all narratives

Nordicus Partners Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nordicus Partners
Historical stock prices
Current Share PriceUS$3.94
52 Week HighUS$5.95
52 Week LowUS$1.48
Beta-0.56
1 Month Change79.13%
3 Month Change5.09%
1 Year Change29.21%
3 Year Change-43.70%
5 Year Changen/a
Change since IPO-28.35%

Recent News & Updates

Recent updates

Shareholder Returns

NORDUS BiotechsUS Market
7D-1.5%-5.3%-1.0%
1Y29.2%37.0%14.1%

Return vs Industry: NORD underperformed the US Biotechs industry which returned 34.6% over the past year.

Return vs Market: NORD exceeded the US Market which returned 13.1% over the past year.

Price Volatility

Is NORD's price volatile compared to industry and market?
NORD volatility
NORD Average Weekly Movement29.4%
Biotechs Industry Average Movement9.6%
Market Average Movement6.9%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: NORD's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: NORD's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1993n/aHenrik Roufnordicuspartners.com

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023.

Nordicus Partners Corporation Fundamentals Summary

How do Nordicus Partners's earnings and revenue compare to its market cap?
NORD fundamental statistics
Market capUS$75.64m
Earnings (TTM)-US$4.00m
Revenue (TTM)n/a
0.0x
P/S Ratio
-18.9x
P/E Ratio

Is NORD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NORD income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$4.00m
Earnings-US$4.00m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.21
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.09%

How did NORD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/12 06:46
End of Day Share Price 2026/09/10 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nordicus Partners Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.